Nirmatrelvir & Ritonavir Tablets Rescuevid: A New Oral Medicine for COVID-19 in India

COVID-19 is a global pandemic that has affected millions of people and caused many deaths. The disease is caused by a new coronavirus that can infect the respiratory system and other organs. The symptoms of COVID-19 can range from mild to severe, and some people may develop serious complications, such as pneumonia, blood clots, organ failure, or death.

There is no specific cure for COVID-19, but there are several treatments and medications that can help reduce the severity of the infection and prevent hospitalization or death. One of the most promising treatments is Rescuevid, a new oral drug that has been approved by the Drugs Controller General of India (DCGI) and the World Health Organization (WHO) for mild to moderate COVID-19 in adults and children aged 12 years and older weighing at least 40 kg who are at higher risk of severe illness.

What is Rescuevid Tablet?

Rescuevid is a combination of two antiviral drugs: Nirmatrelvir and Ritonavir. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor, which means that it blocks an enzyme that the virus needs to replicate. Ritonavir is an HIV antiretroviral drug that boosts the levels of Nirmatrelvir in the body and enhances its effectiveness.

Rescuevid is manufactured by Health Biotech, one of India’s leading pharmaceutical companies with a global reach. Health Biotech entered into a non-exclusive voluntary licensing agreement with Medicines Patent Pool (MPP) for manufacturing and selling a generic version of Pfizer’s COVID-19 oral antiviral drug Paxlovid, which contains the same active ingredients as Rescuevid.

How does Rescuevid Tablet work?

Rescuevid works by preventing the growth and multiplication of the coronavirus in the body. By inhibiting the viral protease enzyme, Nirmatrelvir & Ritonavir Tablets Price stops the virus from making new copies of itself. By increasing the concentration of Nirmatrelvir, Ritonavir ensures that enough drug reaches the infected cells and prevents the virus from escaping or developing resistance.

By reducing the viral load, Rescuevid can help alleviate the symptoms of COVID-19 and prevent the disease from progressing to severe stages. Rescuevid can also reduce the risk of transmission to others by lowering the amount of virus in the respiratory tract.

How effective is Rescuevid Tablet?

Rescuevid has been shown to be highly effective in reducing the risk of hospitalization or death due to COVID-19. According to clinical trials conducted by Pfizer, Paxlovid reduced the risk of hospitalization or death by 89% compared to placebo in high-risk patients who started treatment within three days of symptom onset. The results were similar for patients who started treatment within five days of symptom onset.

According to Health Biotech, Rescuevid has also demonstrated comparable efficacy and safety to Paxlovid in clinical trials conducted in India. Rescuevid has received emergency use authorization (EUA) from the DCGI and prequalification from the WHO, which means that it meets the quality, safety, and efficacy standards for treating COVID-19.

How to use Rescuevid Tablet?

Rescuevid is available as a combi pack that contains Nirmatrelvir 150 mg (2 tablets) and Ritonavir 100 mg (1 tablet). It is prescribed by a doctor and should be taken as soon as possible after a diagnosis of COVID-19 and within five days of symptom onset. The recommended dose is two tablets of Nirmatrelvir and one tablet of ritonavir twice a day for five consecutive days. Rescuevid can be taken with or without food.

Rescuevid should not be given to children below 12 years of age or weighing less than 40 kg. It should also not be taken by people who are allergic to Nirmatrelvir or Ritonavir or have severe liver or kidney disease. Rescuevid may interact with other medicines, so it is important to inform your doctor about all the medicines you are taking before starting Rescuevid.

What are the side effects of Rescuevid Tablet?

Rescuevid is generally well tolerated and has mild to moderate side effects. The most common side effects are taste change, diarrhea, vomiting, high blood pressure, and muscle pain. These side effects usually go away after stopping Rescuevid.

However, some people may experience serious side effects, such as allergic reactions, liver problems, heart problems, bleeding problems, or drug resistance. If you notice any signs of these side effects, such as rash, difficulty breathing, yellowing of the skin or eyes, chest pain, irregular heartbeat, blood in urine or stool, or worsening symptoms of COVID-19, you should seek immediate medical attention.

Conclusion:

Rescuevid is a new oral drug that can help treat mild to moderate COVID-19 in high-risk adults and children in India. It is a combination of two antiviral drugs that work by blocking the virus from replicating and spreading in the body. It can reduce the risk of hospitalization or death due to COVID-19 by 89%. It is approved by the DCGI and the WHO and manufactured by Health Biotech in India. It should be taken as soon as possible after a diagnosis of COVID-19 and within five days of symptom onset. It has mild to moderate side effects, but some people may experience serious side effects that require medical attention.

Rescuevid is a breakthrough in the fight against COVID-19 and can help save lives and prevent severe outcomes. However, it is not a substitute for vaccination and prevention measures. The best way to protect yourself and others from COVID-19 is to get vaccinated and follow the public health guidelines, such as wearing a mask, washing your hands, avoiding crowds, and staying home if you are sick.

Medical Disclaimer:

In order to legally purchase this medicine from LetsMeds, you’ll require a prescription from your Registered Medical Practitioner.

Note:

All content found on LetsMeds, including medicine uses, dosage/administration, adverse effects, and storage details are created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always consult your doctor or other qualified health professionals if you have any questions regarding your health, medicine, or medical condition. 

ABOUT NOVISOF L

NOVISOF L is a combination of two hepatitis C virus (HCV) antiviral drugs in a single form. Each single tablet contains ledipasvir and sofosbuvir.

MEDICINAL USES :

NOVISOF L is a combination of ledipasvir and sofosbuvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.

NOVISOF L COMMON SIDE EFFECTS :

Tiredness, headache, nausea, diarrhea, or difficulty sleeping may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.

A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

SAFETY INFORMATION Precautions :

·        
Before taking
ledipasvir/sofosbuvir, tell your doctor or pharmacist if you are allergic to
either of the drugs; or if you have any other allergies. This product may
contain inactive ingredients, which can cause allergic reactions or other
problems. Talk to your pharmacist for more details.

·        
Before using this
medication, tell your doctor or pharmacist your medical history, especially of:
kidney disease.

·        
Before having
surgery, tell your doctor or dentist about all the products you use (including
prescription drugs, nonprescription drugs, and herbal products).

·        
During pregnancy,
this medication should be used only when clearly needed. Discuss the risks and
benefits with your doctor. Ledipasvir/sofosbuvir, in combination with
ribavirin, must not be used during pregnancy by either the pregnant woman or
her male partner. The combination may harm an unborn baby.

·        
Two reliable
forms of birth control (such as condoms, birth control pills) must be used
whenever at least one sexual partner is using these medicines together, and for
six months after stopping treatment. If you or your partner becomes pregnant,
or if you think you or your partner may be pregnant, tell your doctor right
away.

·        
It is unknown if
this medication passes into breast milk. Consult your doctor before
breast-feeding. Breast-feeding is not recommended if this medication is used in
combination with ribavirin.

PROPER STORAGE OF NOVISOF L :

Store Novisof L at room temperature below 86°F (30°C).

NOVISOF L INTERACTIONS :

Some products that may interact with this drug include: amiodarone, a certain other medication used to treat chronic hepatitis C (simeprevir).

This medication can slow down the removal of other medications from your body, which may affect how they work. One example is rosuvastatin, among others.

Other medications can affect the removal of ledipasvir/sofosbuvir from your body, which may affect how this medication works. Examples include rifamycins (such as rifampin, rifabutin), St. John’s wort, tipranavir/ritonavir, drugs used to treat seizures (such as phenobarbital, carbamazepine, phenytoin), among others.

Do not take this medication with other products that contain sofosbuvir.

This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist.

WHAT IS NUBLAST CAPSULES?

Temozolomide interferes with the
development of cancer cells, slowing their growth and spread in the body.
Temozolomide is an anti-cancer (“antineoplastic” or
“cytotoxic”) chemotherapy drug.  This medication is classified
as an “alkylating agent.

USES OF NUBLAST CAPSULES:

Temozolomide is used for the treatment
of anaplastic astrocytoma, glioblastoma multiforme (GBM) (types of brain tumors).
Temozolomide is classified as an alkylating agent.  Alkylating agents are
most active in the resting phase of the cell.  These drugs are cell-cycle
non-specific. Temozolomide is similar to the drug dacarbazine.  It acts as
a “pro-drug” meaning it needs to be transformed to its active (cancer
fighting) form by the body’s metabolism.

POSSIBLE SIDE EFFECTS:

seizure (convulsions); fever, chills,
dry cough, feeling short of breath;
easy bruising, unusual bleeding (nose, mouth, vagina, or
rectum), purple or red pinpoint spots under your skin;
low white blood cell counts–fever, swollen gums, painful
mouth sores, pain when swallowing, skin sores, cold or flu symptoms, cough,
trouble breathing; or
liver problems–nausea, upper stomach pain, itching, tired
feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing
of the skin or eyes).

COMMON SIDE EFFECTS MAY
INCLUDE:

bruising, skin rash; loss of movement on
one side of the body; nausea, vomiting, loss of appetite;
diarrhea, constipation; headache, tired feeling, memory
problems; dizziness, weakness, loss of coordination;
sleep problems (insomnia); low white blood cell counts
(fever, flu symptoms); or hair loss.
This is not a complete list of side effects and others may
occur. Call your doctor for medical advice about side effects.

Nublast are Rash, Headache, Dizziness,
Convulsion, Coordination disorder, Insomnia (difficulty in sleeping), Vomiting,
Weakness, Nausea, Loss of appetite, Hair loss, Fatigue, Fever, Diarrhoea,
Memory loss, Constipation, Hemiparesis (weakness on one side of the body.

DRUGS INTERACTIONS: 

Take this medicine in the dose and
duration as advised by your doctor. Swallow it as a whole. Do not chew, crush
or break it. Nublast 20 mg Capsule is to be taken empty stomach.

Nublast 20 mg Capsule is an anti-cancer
medication. It enters the brain tissues and works by damaging the genetic
material (DNA and RNA) of the cancer cells. This stops their growth and
multiplication.

DRUGS PRECAUTIONS:

Swallow
full tablets on an empty stomach, one hour before your meal.

Avoid
being near people who are sick or have infections. Consult your doctor if you
develop symptoms of opportunistic infections (such as Pneumocystis jirovecii
pneumonia) and reactivation of infections (such as hepatitis B virus) Using
temozolomide may increase your risk of developing certain types of bone marrow
cancer. Be aware about your specific risk.

You may
be given medication to prevent nausea or other side effects while you are
receiving temozolomide.

Your
blood will be tested frequently during treatment to monitor the side effects of
temozolomide on your blood cells as you may have a small risk of other changes
in blood cells, including leukemia.

Avoid
activities that may increase your risk of bleeding or injury. Use extra care to
prevent bleeding while shaving or brushing your teeth.

Do not
drink alcohol while taking temozolomide.

Do not
drive or operate machinery while using temozolomide as it may make you tired or
sleepy.

Both
male and female patients should take effective contraceptive precautions during
and after 6 months of treatment. Male patients should seek advice on conservation
of sperm prior to treatment as temozolomide treatment may cause infertility.